← SynDRA
ISAMOLTAN
SynDRA canonical compound SYN0001591 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | HTR1B |
| Mechanism of action | Adrenergic receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
Drug classes
- Serotonin 5-HT1 Receptor Antagonists
Cross-references
Synonyms
- Isamoltane
- isamoltane
- 2TP37O5J17
- DTXCID3025671
- RefChem:148885
- Isamoltan [INN]
- (+/-)-Isamoltane
- 1-(propan-2-ylamino)-3-(2-pyrrol-1-ylphenoxy)propan-2-ol
- Isamoltane hemifumarate
- NCGC00024923-02
- Isamoltanum
- Isamoltanum [Latin]
- UNII-2TP37O5J17
- ()-Isamoltane
- Biomol-NT_000121
- ISAMOLTAN [WHO-DD]
- SCHEMBL396956
- BPBio1_000046
- orb1738138
- SCHEMBL30390678
- CHEBI:91607
- XVTVPGKWYHWYAD-UHFFFAOYSA-N
- Tox21_110937
- BDBM50470812
- PDSP1_000008
- PDSP1_000679
- PDSP2_000008
- PDSP2_000669
- NCGC00024923-03
- CAS-116861-00-8
- NS00126761
- L000835
- SR-01000597966
- SR-01000597966-1
- BRD-A26845397-001-01-4
- BRD-A26845397-051-01-9
- 1-iso-propylamino-3[o-(pyrrol-1-yl)-phenoxy]-2-propanol
- (+-)-1-(Isopropylamino)-3-(o-pyrrol-1-ylphenoxy)-2-propanol
Look up ISAMOLTAN in the interactive SynDRA portal →